ANGIODYNAMICS INC (ANGO) research

ANGIODYNAMICS INC

Sector: Health Care
Last price: $15.54
As of: 2026-10-05

Kresmion compiles this page from ANGO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

ANGIODYNAMICS INC (ANGO): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-K filed 2026-07-14.

As of 2026-08-16, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for ANGO. Method and limitations.

COMPANY DOSSIER

See the full ANGO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ANGO on one page. Preview it with sample data, then open it live with a free account.

Preview the ANGO dossier

Active signals for ANGO

highINSTITUTIONAL_EXIT2026-08-16
CITADEL ADVISORS LLC cut 75% of ANGO (2026Q2)
All 2026-08-16 signals →
mediumEARNINGS_BEAT2026-07-29
Q3-2026: Beat consensus by 117.8%, EPS $0.02 vs $-0.1122 estimate
All 2026-07-29 signals →
mediumEARNINGS_BEAT2026-07-29
Q4-2026: Beat consensus by 23.7%, EPS $-0.07 vs $-0.0918 estimate
All 2026-07-29 signals →

FREE, NO ACCOUNT

Every signal on ANGO, as it fires

New filings, 13F moves and cross asset signals on ANGO land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in ANGO (2026Q2)

Manager / security	Market value	% portfolio	QoQ
Point72 Asset Management, L.P.CUSIP 03475V101 · 2026Q2	$39.8M	0.04%	,
MILLENNIUM MANAGEMENT LLCCUSIP 03475V101 · 2026Q2	$10.2M	0.00%	,
RENAISSANCE TECHNOLOGIES LLCCUSIP 03475V101 · 2026Q2	$9.5M	0.01%	,
TWO SIGMA INVESTMENTS, LPCUSIP 03475V101 · 2026Q2	$4M	0.00%	,
CITADEL ADVISORS LLCCUSIP 03475V101 · 2026Q2	$162K	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, ANGO

10-K2026-07-14
SEC EDGAR ↗
8-K2026-07-14
SEC EDGAR ↗
8-K2026-04-23
SEC EDGAR ↗
8-K2026-04-02
SEC EDGAR ↗
10-Q2026-04-02
SEC EDGAR ↗
8-K2026-02-03
SEC EDGAR ↗
8-K2026-01-14
SEC EDGAR ↗
8-K2026-01-06
SEC EDGAR ↗
10-Q2026-01-06
SEC EDGAR ↗
8-K2025-11-12
SEC EDGAR ↗

ANGO against its peers

ANGO's operating margin of -12.5% ranks in the 27th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-05-31.

Metric	ANGO	Peer median	Percentile	n
Revenue FY	320M USD	781M USD	35	23
Gross margin	54.6%	63.7%	46	11
Operating margin	-12.5%	-2.0%	27	23
Net margin	-11.5%	-4.9%	31	23
Return on equity	-21.5%	-5.3%	33	22
P / E	n/a	48.0x	n/a	7

Peers (23): FLGT, EHAB, AHCO, SGHT, CERS, TALK, HSTM, BVS, CCRN, PRCT, TDOC, EVH, CSTL, IRMD, GDRX, CTEV, STAA, TNDM, OMDA, USPH, PNTG, CNMD, AMN. Left out: VREX (period gap), SLP (period gap). Fiscal periods ending between 2025-12-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (ANGO: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Follow ANGO on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ANGO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.